Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-25 @ 11:34 PM
NCT ID: NCT02943993
Description: Treatment-emergent adverse events were not assessed in this non-interventional (observational) study. Adverse drug reactions were reported as a secondary outcome measure.
Frequency Threshold: 0
Time Frame: Treatment-emergent adverse events were not assessed in this non-interventional (observational) study.
Study: NCT02943993
Study Brief: Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ETNA-VTE Participants with established acute initial or recurrent VTE who were treated with edoxaban according to Summary of Product Characteristics (SmPC) based on the clinical decision of the treating physician. 98 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):